Literature DB >> 17617667

Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomics.

Amol Prakash1, Brian Piening, Jeff Whiteaker, Heidi Zhang, Scott A Shaffer, Daniel Martin, Laura Hohmann, Kelly Cooke, James M Olson, Stacey Hansen, Mark R Flory, Hookeun Lee, Julian Watts, David R Goodlett, Ruedi Aebersold, Amanda Paulovich, Benno Schwikowski.   

Abstract

Mass spectrometry-based proteomics holds great promise as a discovery tool for biomarker candidates in the early detection of diseases. Recently much emphasis has been placed upon producing highly reliable data for quantitative profiling for which highly reproducible methodologies are indispensable. The main problems that affect experimental reproducibility stem from variations introduced by sample collection, preparation, and storage protocols and LC-MS settings and conditions. On the basis of a formally precise and quantitative definition of similarity between LC-MS experiments, we have developed Chaorder, a fully automatic software tool that can assess experimental reproducibility of sets of large scale LC-MS experiments. By visualizing the similarity relationships within a set of experiments, this tool can form the basis of systematic quality control and thus help assess the comparability of mass spectrometry data over time, across different laboratories, and between instruments. Applying Chaorder to data from multiple laboratories and a range of instruments, experimental protocols, and sample complexities revealed biases introduced by the sample processing steps, experimental protocols, and instrument choices. Moreover we show that reducing bias by correcting for just a few steps, for example randomizing the run order, does not provide much gain in statistical power for biomarker discovery.

Mesh:

Substances:

Year:  2007        PMID: 17617667     DOI: 10.1074/mcp.M600470-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  20 in total

1.  Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides.

Authors:  Douglas W Mahoney; Terry M Therneau; Carrie J Heppelmann; Leeann Higgins; Linda M Benson; Roman M Zenka; Pratik Jagtap; Gary L Nelsestuen; H Robert Bergen; Ann L Oberg
Journal:  J Proteome Res       Date:  2011-08-02       Impact factor: 4.466

2.  Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA.

Authors:  Ann L Oberg; Douglas W Mahoney; Jeanette E Eckel-Passow; Christopher J Malone; Russell D Wolfinger; Elizabeth G Hill; Leslie T Cooper; Oyere K Onuma; Craig Spiro; Terry M Therneau; H Robert Bergen
Journal:  J Proteome Res       Date:  2008-01-04       Impact factor: 4.466

3.  A method for monitoring and controlling reproducibility of intensity data in complex electrospray mass spectra: a thermometer ion-based strategy.

Authors:  Paolo Lecchi; Jinghua Zhao; Wesley S Wiggins; Tzong-Hao Chen; Ping F Yip; Brian C Mansfield; John M Peltier
Journal:  J Am Soc Mass Spectrom       Date:  2008-11-06       Impact factor: 3.109

4.  Characterization of early autophagy signaling by quantitative phosphoproteomics.

Authors:  Kristoffer Tg Rigbolt; Mostafa Zarei; Adrian Sprenger; Andrea C Becker; Britta Diedrich; Xun Huang; Sven Eiselein; Anders R Kristensen; Christine Gretzmeier; Jens S Andersen; Zhike Zi; Jörn Dengjel
Journal:  Autophagy       Date:  2013-11-21       Impact factor: 16.016

5.  Global Analysis of SUMO-Binding Proteins Identifies SUMOylation as a Key Regulator of the INO80 Chromatin Remodeling Complex.

Authors:  Eric Cox; Woochang Hwang; Ijeoma Uzoma; Jianfei Hu; Catherine M Guzzo; Junseop Jeong; Michael J Matunis; Jiang Qian; Heng Zhu; Seth Blackshaw
Journal:  Mol Cell Proteomics       Date:  2017-03-02       Impact factor: 5.911

6.  Identification of target proteins involved in cochlear otosclerosis.

Authors:  Céline Richard; Joni K Doherty; Jose N Fayad; Ana Cordero; Fred H Linthicum
Journal:  Otol Neurotol       Date:  2015-06       Impact factor: 2.311

7.  Defining, comparing, and improving iTRAQ quantification in mass spectrometry proteomics data.

Authors:  Lina Hultin-Rosenberg; Jenny Forshed; Rui M M Branca; Janne Lehtiö; Henrik J Johansson
Journal:  Mol Cell Proteomics       Date:  2013-03-07       Impact factor: 5.911

8.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 9.  Quality assessment for clinical proteomics.

Authors:  David L Tabb
Journal:  Clin Biochem       Date:  2012-12-12       Impact factor: 3.281

10.  Statistical quality assessment and outlier detection for liquid chromatography-mass spectrometry experiments.

Authors:  Ole Schulz-Trieglaff; Egidijus Machtejevas; Knut Reinert; Hartmut Schlüter; Joachim Thiemann; Klaus Unger
Journal:  BioData Min       Date:  2009-04-07       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.